Data from the MiDAS I clinical trial showed that patients undergoing Vertos Medical's mild procedure for lumbar spinal stenosis reported statistically significant improvement both physically and mentally, according to a Vertos news release.
The study, by the Florida Society of Interventional Pain Physicians, evaluated mild patients six weeks following the procedure using the Zurich Claudication Questionnaire. Patients rated their overall satisfaction at a 2.02 on a scale from 1 to 4, with 1 being the highest score.
Vertos mild is FDA-approved for treating central canal stenosis of the lumbar spine.
Read the Vertos release on the MiDAS I clinical trial (pdf).